Gene expression profiling methods can potentially be used to classify disease states and to select genes, pathways, and differential expression signatures that may be correlated with patient prognosis in the future. This webinar explores the use of next-generation sequencing (NGS) and, in particular, transcriptome sequencing using the Ion AmpliSeq Transcriptome Human Gene Expression Kit, to identify biomarkers that may be used to unravel dysregulated molecular pathways research.
Identification of Genetic Determinants Found in Multiple Sclerosis Research by Exome and Transcriptome Profiling
Carles Vilariño-Güell, PhD, The University of British Columbia
The webinar will be followed by a Q&A session.
About the presenter
Dr. Vilariño-Güell’s primary research interest is in neurological and neurodegenerative disorders, primarily multiple sclerosis and related disorders. His research focuses on familial genetics, genomics, statistics, and computational biology.
Fill in the form to view the free on-demand webinar.
For Research Use Only.